The AstraZeneca-University of Oxford COVID-19 vaccine has created immune responses in young and old adults, a promising sign that the shot could provide protection from the coronavirus.
The shot, now in late-stage human trials, also triggered lower adverse responses among the elderly, the sector of the population most vulnerable to serious illness. The company said in an announcement Monday that is likely to boost hopes that a COVID-19 vaccine is right around the corner.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.